These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 30507617)

  • 1. Supervised Classification of CYP2D6 Genotype and Metabolizer Phenotype With Postmortem Tramadol-Exposed Finns.
    Wendt FR; Novroski NMM; Rahikainen AL; Sajantila A; Budowle B
    Am J Forensic Med Pathol; 2019 Mar; 40(1):8-18. PubMed ID: 30507617
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Concentrations of tramadol and O-desmethyltramadol enantiomers in different CYP2D6 genotypes.
    Stamer UM; Musshoff F; Kobilay M; Madea B; Hoeft A; Stuber F
    Clin Pharmacol Ther; 2007 Jul; 82(1):41-7. PubMed ID: 17361124
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A pathway-driven predictive model of tramadol pharmacogenetics.
    Wendt FR; Novroski NMM; Rahikainen AL; Sajantila A; Budowle B
    Eur J Hum Genet; 2019 Jul; 27(7):1143-1156. PubMed ID: 30824817
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pharmacokinetics of tramadol enantiomers and their respective phase I metabolites in relation to CYP2D6 phenotype.
    García-Quetglas E; Azanza JR; Sádaba B; Muñoz MJ; Gil I; Campanero MA
    Pharmacol Res; 2007 Feb; 55(2):122-30. PubMed ID: 17175164
    [TBL] [Abstract][Full Text] [Related]  

  • 5. CYP2D6 polymorphism in relation to tramadol metabolism: a study of faroese patients.
    Halling J; Weihe P; Brosen K
    Ther Drug Monit; 2008 Jun; 30(3):271-5. PubMed ID: 18520597
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Post-mortem SNP analysis of CYP2D6 gene reveals correlation between genotype and opioid drug (tramadol) metabolite ratios in blood.
    Levo A; Koski A; Ojanperä I; Vuori E; Sajantila A
    Forensic Sci Int; 2003 Jul; 135(1):9-15. PubMed ID: 12893130
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Tramadol and o-desmethyl tramadol clearance maturation and disposition in humans: a pooled pharmacokinetic study.
    Allegaert K; Holford N; Anderson BJ; Holford S; Stuber F; Rochette A; Trocóniz IF; Beier H; de Hoon JN; Pedersen RS; Stamer U
    Clin Pharmacokinet; 2015 Feb; 54(2):167-78. PubMed ID: 25258277
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Oxycodone findings and CYP2D6 function in postmortem cases.
    Jakobsson G; Larsson R; Pellè L; Kronstrand R; Gréen H
    Forensic Sci Int Genet; 2021 Jul; 53():102510. PubMed ID: 33799050
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Near-fatal tramadol cardiotoxicity in a CYP2D6 ultrarapid metabolizer.
    Elkalioubie A; Allorge D; Robriquet L; Wiart JF; Garat A; Broly F; Fourrier F
    Eur J Clin Pharmacol; 2011 Aug; 67(8):855-8. PubMed ID: 21691803
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inhibition of CYP2D6-mediated tramadol O-demethylation in methadone but not buprenorphine maintenance patients.
    Coller JK; Michalakas JR; James HM; Farquharson AL; Colvill J; White JM; Somogyi AA
    Br J Clin Pharmacol; 2012 Nov; 74(5):835-41. PubMed ID: 22369095
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of the cytochrome P450 2D6*10 genotype on the pharmacokinetics of tramadol in post-operative patients.
    Xu J; Zhang XC; Lv XQ; Xu YY; Wang GX; Jiang B; Cai L; Cai XJ
    Pharmazie; 2014 Feb; 69(2):138-41. PubMed ID: 24640604
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pharmacogenetic aspects of tramadol pharmacokinetics and pharmacodynamics after a single oral dose.
    Bastami S; Haage P; Kronstrand R; Kugelberg FC; Zackrisson AL; Uppugunduri S
    Forensic Sci Int; 2014 May; 238():125-32. PubMed ID: 24709712
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of the CYP2D6 gene duplication on the pharmacokinetics and pharmacodynamics of tramadol.
    Kirchheiner J; Keulen JT; Bauer S; Roots I; Brockmöller J
    J Clin Psychopharmacol; 2008 Feb; 28(1):78-83. PubMed ID: 18204346
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A rapid and simple CYP2D6 genotyping assay--case study with the analgetic tramadol.
    Borlak J; Hermann R; Erb K; Thum T
    Metabolism; 2003 Nov; 52(11):1439-43. PubMed ID: 14624403
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Involvement of CYP2D6 and CYP2B6 on tramadol pharmacokinetics.
    Saiz-Rodríguez M; Ochoa D; Román M; Zubiaur P; Koller D; Mejía G; Abad-Santos F
    Pharmacogenomics; 2020 Jul; 21(10):663-675. PubMed ID: 32538291
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Relationship of CYP2D6 genetic polymorphisms and the pharmacokinetics of tramadol in Chinese volunteers.
    Li Q; Wang R; Guo Y; Wen S; Xu L; Wang S
    J Clin Pharm Ther; 2010 Apr; 35(2):239-47. PubMed ID: 20456744
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Impact of CYP genotype and inflammatory markers on the plasma concentrations of tramadol and its demethylated metabolites and drug tolerability in cancer patients.
    Tanaka H; Naito T; Sato H; Hiraide T; Yamada Y; Kawakami J
    Eur J Clin Pharmacol; 2018 Nov; 74(11):1461-1469. PubMed ID: 30051214
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of terbinafine and itraconazole on the pharmacokinetics of orally administered tramadol.
    Saarikoski T; Saari TI; Hagelberg NM; Backman JT; Neuvonen PJ; Scheinin M; Olkkola KT; Laine K
    Eur J Clin Pharmacol; 2015 Mar; 71(3):321-7. PubMed ID: 25560051
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Full-gene haplotypes refine CYP2D6 metabolizer phenotype inferences.
    Wendt FR; Sajantila A; Moura-Neto RS; Woerner AE; Budowle B
    Int J Legal Med; 2018 Jul; 132(4):1007-1024. PubMed ID: 29075918
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Differential Consequences of Tramadol in Overdosing: Dilemma of a Polymorphic Cytochrome P450 2D6-Mediated Substrate.
    Srinivas NR
    J Pain Palliat Care Pharmacother; 2015 Sep; 29(3):272-5. PubMed ID: 26367475
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.